Free tool
Stocks near their 52-week high
We cover 71 companies trading within 5% of their own 52-week high. The median market value in the group is $6.24B. Across the group, the median move over the past trading day is −0.15%. 100% of the 71 with a 200-day average trade above it. Price change over the past year runs from +18.4% to +206.5% across the middle 80 percent of the group, with a median of +56.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
71 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +110.53% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.